Plus therapeutics to present at 13th annual ld micro main event conference

Austin, texas, dec. 08, 2020 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage company focused on making a positive impact on patients' lives, today announced that marc hedrick, m.d., president and chief executive officer of plus therapeutics, has been invited to present a company overview during the 13th annual ld micro main event conference on monday, december 14th at 10:40 a.m. et.
pstv Ratings Summary
pstv Quant Ranking